Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs in pancreatic ductal adenocarcinoma (PDAC). Updated clinical data from the...
2025 World Brain Day Dedicated to Brain Health for All Ages
LONDON, May 28, 2025 /PRNewswire/ -- The World Federation of Neurology (WFN) is pleased to announce Brain Health for All Ages as the theme for the 2025 World Brain Day (WBD 2025), taking place on Tuesday, July 22. This global campaign aims to raise awareness of the importance of supporting brain health...
Perennial Holdings Signs Agreement with Guangzhou Metro to Establish the First Wholly Foreign-Owned Tertiary General Hospital in Guangzhou and Southern China
SINGAPORE, May 28, 2025 /PRNewswire/ -- Perennial Holdings Private Limited ("Perennial Holdings") entered into an agreement with Guangzhou Metro Group Co. Ltd ("Guangzhou Metro"), where Perennial Holdings will lease approximately 105,000 square metres of space and invest approximately RMB1 billion to establish a tertiary general hospital and a specialist hospital at the...
CARsgen’s Satri-cel Granted Priority Review by the NMPA
SHANGHAI, May 28, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Priority Review to satricabtagene autoleucel ("satri-cel", CT041)(an autologous CAR T-cell product candidate against...
Exclusive Global 20 Seats, China’s Sole One! KT-939 Was Successfully Selected for 2025 NYSCC Inspiration Hive Zone
SUZHOU, China, May 28, 2025 /PRNewswire/ -- In the newly announced entry list of the Inspiration Hive zone at the 2025 New York Society of Cosmetic Chemists (NYSCC) exhibition, Kintor's innovative ingredient KT-939 has been selected as the only "Chinese Ingredient" among the numerous global ones. It will compete with global industry giants such as Ashland, DSM-Firmenich, and Eastman,...
Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System
– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures – SOMERSET, N.J., May 28, 2025 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System....
Digital Supply Chain Transformation Accelerates in Life Sciences as New Partners Join the TraceLink OPUS Partner Program
BOSTON, May 27, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, announced significant momentum in its OPUS Partner Program, which has grown by 35% since April 2024. This growth reflects surging demand across life sciences for digital supply chain transformation—and trusted...
NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN rise in their first full day of trade
NEW YORK, May 27, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on May 27th Stocks are rising Tuesday...
HKSH Fosters Collaboration for Innovation at Asia Summit on Global Health 2025, Through Partnership with United Imaging to Elevate Medical Imaging Excellence
HONG KONG, May 27, 2025 /PRNewswire/ -- The HKSH Medical Group (HKSH) has for over a century been committed to acquiring the state-of-the-art, world-class technology and facilities to deliver excellent and advanced medical services. Mr. Wyman LI, Chief Operating Officer of HKSH Medical Group, Director of Hong Kong Sanatorium & Hospital, and Governor of The Li Shu Fan...
Visionary Holdings’ Changle Shuang Carries Out Biotechnology Health Public Welfare Activities for Society
TORONTO, May 27, 2025 /PRNewswire/ -- On May 23, 2025, Changle Shuang, a subsidiary of Visionary Holdings (Nasdaq: GV), officially reached a strategic partnership with the Guangzhou Jianjia Charity Foundation in Guangzhou. The two parties signed a strategic cooperation agreement around the "Healthy Stomach Future, Early Screening for Peace of Mind" national free Helicobacter pylori (Hp) screening campaign, planning to...
